• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

作者信息

Khan S A, Davidson B R, Goldin R, Pereira S P, Rosenberg W M C, Taylor-Robinson S D, Thillainayagam A V, Thomas H C, Thursz M R, Wasan H

机构信息

Liver Unit, Department of Medicine A, Imperial College School of Medicine, St Mary's Hospital Campus, South Wharf Street, London W2 1PG, UK.

出版信息

Gut. 2002 Nov;51 Suppl 6(Suppl 6):VI1-9. doi: 10.1136/gut.51.suppl_6.vi1.

DOI:10.1136/gut.51.suppl_6.vi1
PMID:12376491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1867742/
Abstract
摘要

相似文献

1
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.胆管癌诊疗指南：共识文件
Gut. 2002 Nov;51 Suppl 6(Suppl 6):VI1-9. doi: 10.1136/gut.51.suppl_6.vi1.
2
Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.提高肝内胆管癌患者生存率是否可行？一例病例报告。
J Gastrointest Cancer. 2021 Mar;52(1):342-346. doi: 10.1007/s12029-020-00446-4.
3
Preoperative assessment of cholangiocarcinoma: meeting the challenge.胆管癌的术前评估：应对挑战
J Gastroenterol Hepatol. 1999 Jul;14(7):615-7. doi: 10.1046/j.1440-1746.1999.01927.x.
4
[The differences between intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma -from diagnosis and biliary drainage points of view].[肝内胆管癌与肝门部胆管癌的差异——从诊断和胆道引流角度来看]
Nihon Shokakibyo Gakkai Zasshi. 2016 Sep;113(9):1533-40. doi: 10.11405/nisshoshi.113.1533.
5
Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of China.胆管癌的诊断与治疗：中国外科专家共识
J Huazhong Univ Sci Technolog Med Sci. 2014 Aug;34(4):469-475. doi: 10.1007/s11596-014-1301-5. Epub 2014 Aug 19.
6
Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.内镜下置入鼻胆管用于高剂量率近距离放射治疗作为肝门周围胆管癌新辅助治疗的一部分。
Endoscopy. 2015 Oct;47(10):878-83. doi: 10.1055/s-0034-1392044. Epub 2015 May 11.
7
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.肝内胆管癌诊断和管理指南
J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27.
8
[Common bile ductal carcinoma, hilar cholangiocarcinoma: evaluation with MR cholangiography].[胆总管癌、肝门部胆管癌：磁共振胰胆管造影评估]
Nihon Rinsho. 1998 Nov;56(11):2928-32.
9
Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography.肝门部胆管癌：超声、多层螺旋CT、磁共振成像及直接胆管造影术前影像学检查的作用
AJR Am J Roentgenol. 2008 Nov;191(5):1448-57. doi: 10.2214/AJR.07.3992.
10
Liver capsule: Cholangiocarcinoma (CCA).肝包膜：胆管癌（CCA）。
Hepatology. 2016 Apr;63(4):1356. doi: 10.1002/hep.28401. Epub 2016 Feb 1.

引用本文的文献

1
Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE.在无法切除的伴有梗阻性黄疸的胆管癌患者中，经皮经肝胆道引流术联合载药微球肝动脉化疗栓塞术（DEB-TACE）的疗效：与单纯DEB-TACE的比较
Therap Adv Gastroenterol. 2025 Aug 22;18:17562848251360114. doi: 10.1177/17562848251360114. eCollection 2025.
2
Occupational and Environmental Cholangiocarcinoma-Related Toxic Exposures.职业性和环境性与胆管癌相关的有毒暴露
GE Port J Gastroenterol. 2024 Nov 7;32(3):151-160. doi: 10.1159/000541868. eCollection 2025 Jun.
3
Solitary Synchronous Biliary Metastasis in Colorectal Adenocarcinoma.结直肠癌中的孤立性同步性胆管转移
World J Oncol. 2025 Apr;16(2):227-234. doi: 10.14740/wjon2008. Epub 2025 Mar 18.
4
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review.上消化道和下消化道癌的细胞减灭术联合术中腹腔热灌注化疗应用综述
Oncol Rev. 2024 Nov 26;18:1496141. doi: 10.3389/or.2024.1496141. eCollection 2024.
5
Application of imaging technology for the diagnosis of malignancy in the pancreaticobiliary duodenal junction (Review).成像技术在胰胆管十二指肠交界处恶性肿瘤诊断中的应用（综述）
Oncol Lett. 2024 Oct 8;28(6):596. doi: 10.3892/ol.2024.14729. eCollection 2024 Dec.
6
Biliary stents for active materials and surface modification: Recent advances and future perspectives.用于活性材料和表面改性的胆道支架：最新进展与未来展望。
Bioact Mater. 2024 Sep 13;42:587-612. doi: 10.1016/j.bioactmat.2024.08.031. eCollection 2024 Dec.
7
Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models.色氨酸羟化酶抑制剂替罗利司特可增强临床前胆管癌模型中标准化疗的抗肿瘤疗效。
J Cell Mol Med. 2024 Sep;28(17):e18585. doi: 10.1111/jcmm.18585.
8
Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma.鉴定新型铜死亡相关基因，介导胆管癌的预后和免疫微环境。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241239139. doi: 10.1177/15330338241239139.
9
Molecular pathology for cholangiocarcinoma: a review of actionable genetic targets and their relevance to adjuvant & neoadjuvant therapy, staging, follow-up, and determination of minimal residual disease.胆管癌的分子病理学：可操作的遗传靶点及其与辅助和新辅助治疗、分期、随访以及微小残留病判定的相关性综述
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):29-38. doi: 10.21037/hbsn-22-563. Epub 2023 Mar 24.
10
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in -Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS.CP-673451，一种选择性血小板衍生生长因子受体酪氨酸激酶抑制剂，通过抑制Nrf2和增强活性氧诱导肝内胆管癌细胞凋亡。
Pharmaceuticals (Basel). 2023 Dec 20;17(1):9. doi: 10.3390/ph17010009.

本文引用的文献

1
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.1968年至1998年英格兰和威尔士肝内胆管癌死亡率的上升。
Gut. 2001 Jun;48(6):816-20. doi: 10.1136/gut.48.6.816.
2
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.使用[（18）F]氟-2-脱氧-D-葡萄糖的正电子发射断层扫描用于胆管癌的诊断和分期
Hepatology. 2001 May;33(5):1029-35. doi: 10.1053/jhep.2001.23912.
3
Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.单侧与双侧内镜下肝管引流治疗恶性肝门部胆管梗阻患者：一项前瞻性、随机对照研究的结果
Gastrointest Endosc. 2001 May;53(6):547-53. doi: 10.1067/mge.2001.113381.
4
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.肝门部胆管癌的淋巴结转移：对110例行区域及腹主动脉旁淋巴结清扫术患者的审计
Ann Surg. 2001 Mar;233(3):385-92. doi: 10.1097/00000658-200103000-00013.
5
Imaging techniques in patients with biliary obstruction.胆管梗阻患者的成像技术。
Med Sci Monit. 2000 Nov-Dec;6(6):1197-202.
6
Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.伴有和不伴有胆管癌的原发性硬化性胆管炎中的胆管发育异常、细胞增殖和核DNA片段化
J Intern Med. 2001 Jan;249(1):69-75. doi: 10.1046/j.1365-2796.2001.00775.x.
7
Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors.磁共振胰胆管造影引导下的肝门部胆管癌单侧内镜支架置入术
Gastrointest Endosc. 2001 Jan;53(1):40-6. doi: 10.1067/mge.2001.111388.
8
Genes and viruses in hepatobiliary neoplasia.肝胆肿瘤中的基因与病毒
Semin Surg Oncol. 2000 Sep-Oct;19(2):84-93. doi: 10.1002/1098-2388(200009)19:2<84::aid-ssu2>3.0.co;2-0.
9
Early detection and treatment of cholangiocarcinoma.胆管癌的早期检测与治疗。
Liver Transpl. 2000 Nov;6(6 Suppl 2):S30-4. doi: 10.1053/jlts.2000.18688.
10
Treatment options for other hepatic malignancies.其他肝脏恶性肿瘤的治疗选择。
Liver Transpl. 2000 Nov;6(6 Suppl 2):S23-9. doi: 10.1053/jlts.2000.18687.